Clinical Study Data Request
Please note that this site will be unavailable from Friday 23 February to Monday 5 March 2018 for a major upgrade, in order to improve the site for researchers such as yourself who request
patient-level data.
Registered Users, Please Login

Find by:

Study ID:

Phase IIIa randomized, controlled study to assess the immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine, when administered as a 3-dose primary immunization course before 6 months of age
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Infections, Streptococcal
Phase 3
Follow on studies 106623 and 112807 were conducted.
March 2015

Powered by ideaPoint, Inc.